{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:00:38Z","timestamp":1765886438533},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health Canada and the Ministry of Health and Social Services"},{"name":"Fonds de recherche du Qu\u00e9bec - Sant\u00e9","award":["16000"],"award-info":[{"award-number":["16000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Older adults are at risk of potentially inappropriate medication use given polypharmacy, multimorbidity, and age-related changes, which contribute to the growing burden associated with opioid use. The objective of this study was to estimate the costs of health service utilization attributable to opioid use and potentially inappropriate medication use involving\u00a0opioids in older adults in a public health care system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The sample included 1201 older adults consulting in primary care, covered by the public drug plan, without a cancer diagnosis and opioid use in the year before interview. Secondary analyses were conducted using two data sources: health survey and provincial administrative data. Health system costs included inpatient and outpatient visits, physician billing, and medication costs. Unit costs were calculated using annual financial and activity reports from 2013\u20132014, adjusted to 2022 Canadian dollars. Opioid use and potentially inappropriate\u00a0medication use involving opioids were identified over 3\u00a0years. Generalized linear models with gamma distribution were employed to model 3-year costs associated with opioid use and potentially inappropriate\u00a0medication use involving opioids. A phase-based approach was implemented to provide descriptive results on the costs associated with each phase: i) no use, ii) opioid use, and iii) potentially inappropriate medication use involving\u00a0opioids.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Opioid use and potentially inappropriate\u00a0medication use involving opioids were associated with adjusted 3-year costs of $2,222 (95% CI: $1,179-$3,264) and $8,987 (95% CI: $7,370-$10,605), respectively, compared to no use. In phase-based analyses, costs were the highest during inappropriate  use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Potentially inappropriate medication use involving\u00a0opioids is associated with higher costs compared to those observed with opioid use and no use. There is a need for more effective use of health care resources to reduce costs for the health care system.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-023-10303-2","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T06:02:06Z","timestamp":1700805726000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Health care system costs related to potentially inappropriate medication use involving\u00a0opioids in older adults in Canada"],"prefix":"10.1186","volume":"23","author":[{"given":"Carina","family":"D\u2019Aiuto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlotta","family":"Lunghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line","family":"Gu\u00e9nette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djamal","family":"Berbiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen-Maria","family":"Vasiliadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"10303_CR1","unstructured":"Canadian Institute for Substance Use Research (CISUR), Canadian Centre on Substance Use and Addiction (CCSA). Canadian substance use costs and harms 2015\u20132017. 2020. https:\/\/csuch.ca\/publications\/CSUCH-Canadian-Substance-Use-Costs-Harms-Report-2020-en.pdf. Accessed 3 Nov 2020."},{"key":"10303_CR2","unstructured":"Canadian Institute for Health Information (CIHI). Hospitalizations and emergency department visits due to opioid poisoning in Canada. 2016. https:\/\/secure.cihi.ca\/free_products\/Opioid%20Poisoning%20Report%20%20EN.pdf. Accessed 27 July 2022."},{"issue":"1","key":"10303_CR3","first-page":"7","volume":"4","author":"D Kwan","year":"2014","unstructured":"Kwan D, Farrell B. Polypharmacy: optimizing medication use in elderly patients. Can Geriatr Soc J CME. 2014;4(1):7.","journal-title":"Can Geriatr Soc J CME"},{"issue":"11","key":"10303_CR4","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1111\/jgs.16743","volume":"68","author":"CM Clark","year":"2020","unstructured":"Clark CM, Shaver AL, Aurelio LA, Feuerstein S, Wahler RG, Daly CJ, et al. Potentially inappropriate medications are associated with increased healthcare utilization and costs. J Am Geriatr Soc. 2020;68(11):2542\u201350.","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"10303_CR5","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1097\/MLR.0000000000000587","volume":"54","author":"V Hyttinen","year":"2016","unstructured":"Hyttinen V, Jyrkk\u00e4 J, Valtonen H. A systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults. Med Care. 2016;54(10):950\u201364.","journal-title":"Med Care"},{"issue":"3","key":"10303_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1370\/afm.2373","volume":"17","author":"TM Liew","year":"2019","unstructured":"Liew TM, Lee CS, Goh Shawn KL, Chang ZY. Potentially inappropriate prescribing among older persons: a meta-analysis of observational studies. Ann Fam Med. 2019;17(3):257\u201366.","journal-title":"Ann Fam Med"},{"issue":"1","key":"10303_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s41669-019-0143-2","volume":"4","author":"CD Black","year":"2020","unstructured":"Black CD, Thavorn K, Coyle D, Bjerre LM. The health system costs of potentially inappropriate prescribing: a population-based, retrospective cohort study using linked health administrative databases in Ontario, Canada. PharmacoEconomics - Open. 2020;4(1):27\u201336.","journal-title":"PharmacoEconomics - Open"},{"key":"10303_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.vhri.2021.05.003","volume":"25","author":"SK Malakouti","year":"2021","unstructured":"Malakouti SK, Javan-Noughabi J, Yousefzadeh N, Rezapour A, Mortazavi SS, Jahangiri R, et al. A systematic review of potentially inappropriate medications use and related costs among the elderly. Value Health Reg Issues. 2021;25:172\u20139.","journal-title":"Value Health Reg Issues"},{"issue":"2","key":"10303_CR9","doi-asserted-by":"publisher","first-page":"E346","DOI":"10.9778\/cmajo.20150131","volume":"4","author":"SG Morgan","year":"2016","unstructured":"Morgan SG, Hunt J, Rioux J, Proulx J, Weymann D, Tannenbaum C. Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study. CMAJ Open. 2016;4(2):E346\u201351.","journal-title":"CMAJ Open"},{"issue":"1","key":"10303_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1533-2500.2011.00498.x","volume":"12","author":"JV Pergolizzi","year":"2012","unstructured":"Pergolizzi JV, Labhsetwar SA, Puenpatom RA, Ben-Joseph R, Ohsfeldt R, Summers KH. Economic impact of potential drug-drug interactions among osteoarthritis patients taking opioids. Pain Pract. 2012;12(1):33\u201344.","journal-title":"Pain Pract"},{"issue":"1","key":"10303_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1533-2500.2011.00503.x","volume":"12","author":"JV Pergolizzi","year":"2012","unstructured":"Pergolizzi JV, Labhsetwar SA, Puenpatom RA, Ben-Joseph R, Ohsfeldt R, Summers KH. Economic impact of potential CYP450 pharmacokinetic drug-drug interactions among chronic low back pain patients taking opioids. Pain Pract. 2012;12(1):45\u201356.","journal-title":"Pain Pract"},{"issue":"1","key":"10303_CR12","first-page":"e1","volume":"16","author":"KM Stockl","year":"2010","unstructured":"Stockl KM, Le L, Zhang S, Harada ASM. Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Manag Care. 2010;16(1):e1-10.","journal-title":"Am J Manag Care"},{"issue":"2","key":"10303_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.amjopharm.2007.06.005","volume":"5","author":"AS Bierman","year":"2007","unstructured":"Bierman AS, Pugh MJV, Dhalla I, Amuan M, Fincke BG, Rosen A, et al. Sex differences in inappropriate prescribing among elderly veterans. Am J Geriatr Pharmacother. 2007;5(2):147\u201361.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"21","key":"10303_CR14","first-page":"00510","volume":"S0749\u20133797","author":"C Chen","year":"2021","unstructured":"Chen C, Lo-Ciganic WH, Winterstein AG, Tighe P, Wei YJJ. Concurrent Use of Prescription Opioids and Gabapentinoids in Older Adults. Am J Prev Med. 2021;S0749\u20133797(21):00510\u20139.","journal-title":"Am J Prev Med"},{"issue":"8","key":"10303_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gps.5780","volume":"37","author":"C D\u2019Aiuto","year":"2022","unstructured":"D\u2019Aiuto C, Lunghi C, Gu\u00e9nette L, Berbiche D, Pitrou I, Bertrand K, et al. Factors associated with potentially inappropriate opioid use in community-living older adults consulting in primary care. Int J Geriatr Psychiatry. 2022;37(8):1\u201312.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"10303_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S1543-5946(05)80025-X","volume":"3","author":"S Kamal-Bahl","year":"2005","unstructured":"Kamal-Bahl S, Stuart BC, Beers MH. National trends in and predictors of propoxyphene use in community-dwelling older adults. Am J Geriatr Pharmacother. 2005;3(3):186\u201395.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"2","key":"10303_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/gps.5018","volume":"34","author":"N Karttunen","year":"2019","unstructured":"Karttunen N, Taipale H, Hamina A, Tanskanen A, Tiihonen J, Tolppanen A, et al. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer\u2019s disease\u2014A nationwide register-based study in Finland. Int J Geriatr Psychiatry. 2019;34(2):280\u20138.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"10303_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1089\/pop.2019.0128","volume":"23","author":"S Musich","year":"2020","unstructured":"Musich S, Wang SS, Slindee LB, Ruiz J, Yeh CS. Concurrent use of opioids with other central nervous system-active medications among older adults. Popul Health Manag. 2020;23(4):286\u201396.","journal-title":"Popul Health Manag"},{"issue":"2","key":"10303_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/pme.12594","volume":"16","author":"S Nielsen","year":"2015","unstructured":"Nielsen S, Lintzeris N, Bruno R, Campbell G, Larance B, Hall W, et al. Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Med. 2015;16(2):356\u201366.","journal-title":"Pain Med"},{"issue":"10","key":"10303_CR20","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/j.1532-5415.2011.03559.x","volume":"59","author":"MJV Pugh","year":"2011","unstructured":"Pugh MJV, Hanlon JT, Wang C, Semla T, Burk M, Amuan ME, et al. Trends in use of high-risk medications for older veterans: 2004 to 2006. J Am Geriatr Soc. 2011;59(10):1891\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10303_CR21","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1093\/gerona\/gly283","volume":"74","author":"TG Rhee","year":"2019","unstructured":"Rhee TG. Coprescribing of benzodiazepines and opioids in older adults: rates, correlates, and national trends. J Gerontol Ser A. 2019;74(12):1910\u20135.","journal-title":"J Gerontol Ser A"},{"issue":"1","key":"10303_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jgs.15659","volume":"67","author":"AJ Rose","year":"2019","unstructured":"Rose AJ, McBain R, Schuler MS, LaRochelle MR, Ganz DA, Kilambi V, et al. Effect of age on opioid prescribing, overdose, and mortality in Massachusetts, 2011 to 2015. J Am Geriatr Soc. 2019;67(1):128\u201332.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10303_CR23","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"American Geriatrics Society","year":"2019","unstructured":"American Geriatrics Society. American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10303_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/pds.1357","volume":"16","author":"S Suissa","year":"2007","unstructured":"Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 2007;16(3):241\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10303_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/CEOR.S31552","volume":"4","author":"HC Wijeysundera","year":"2012","unstructured":"Wijeysundera HC, Wang X, Tomlinson G, Ko DT, Krahn MD. Techniques for estimating health care costs with censored data: an overview for the health services researcher. Clin Outcomes Res. 2012;4:145.","journal-title":"Clin Outcomes Res"},{"issue":"8","key":"10303_CR26","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/070674371405900805","volume":"59","author":"M Pr\u00e9ville","year":"2014","unstructured":"Pr\u00e9ville M, Mechakra-Tahiri SD, Vasiliadis HM, Mathieu V, Quesnel L, Gontijo-Guerra S, et al. Family violence among older adult patients consulting in primary care clinics: results from the ESA (Enqu\u00eate sur la sant\u00e9 des a\u00een\u00e9s) Services study on mental health and aging. Can J Psychiatry. 2014;59(8):426\u201333.","journal-title":"Can J Psychiatry"},{"key":"10303_CR27","unstructured":"Canadian Agency for Drugs Technologies in Health (CADTH). Guidelines for the Economic Evaluation of Health Technologies: Canada. 4th ed. 2017. https:\/\/www.cadth.ca\/guidelines-economic-evaluation-health-technologies-canada-4th-edition. Accessed 2 Feb 2020."},{"key":"10303_CR28","unstructured":"Drummond M, Sculpher M, Claxton K, Stoddart G, Torrance G. Methods for the economic evaluation of health care programmes. 4th ed. Oxford University Press; 2015."},{"issue":"6","key":"10303_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/070674370004500603","volume":"45","author":"D Reinharz","year":"2000","unstructured":"Reinharz D, Lesage AD, Contandriopoulos AP. Cost-Effectiveness Analysis of Psychiatric Deinstitutionalization. Can J Psychiatry. 2000;45(6):533\u20138.","journal-title":"Can J Psychiatry"},{"issue":"6","key":"10303_CR30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jagp.2012.12.016","volume":"21","author":"HM Vasiliadis","year":"2013","unstructured":"Vasiliadis HM, Dionne PA, Pr\u00e9ville M, Gentil L, Berbiche D, Latimer E. The excess healthcare costs associated with depression and anxiety in elderly living in the community. Am J Geriatr Psychiatry. 2013;21(6):536\u201348.","journal-title":"Am J Geriatr Psychiatry"},{"key":"10303_CR31","unstructured":"Minist\u00e8re de la Sant\u00e9 et des Services sociaux (MSSS). AS-471 \u2013 Rapports financiers annuels des \u00e9tablissements - Donn\u00e9es Qu\u00e9bec. 2018. https:\/\/www.donneesquebec.ca\/recherche\/dataset\/as-471-rapports-financiers-annuels-des-etablissements. Accessed 26 Jan 2022."},{"issue":"1","key":"10303_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12888-022-03759-9","volume":"22","author":"C Lamoureux-Lamarche","year":"2022","unstructured":"Lamoureux-Lamarche C, Berbiche D, Vasiliadis HM. Health care system and patient costs associated with receipt of minimally adequate treatment for depression and anxiety disorders in older adults. BMC Psychiatry. 2022;22(1):175.","journal-title":"BMC Psychiatry"},{"key":"10303_CR33","unstructured":"Statistics Canada. Consumer Price Index by product group, monthly, percentage change, not seasonally adjusted, Canada, provinces, Whitehorse, Yellowknife and Iqaluit. 2007. https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1810000413. Accessed 10 Nov 2022."},{"issue":"6","key":"10303_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/BF00707261","volume":"21","author":"R Rosenheck","year":"1994","unstructured":"Rosenheck R, Frisman L, Neale M. Estimating the capital component of mental health care costs in the public sector. Adm Policy Ment Health. 1994;21(6):493\u2013509.","journal-title":"Adm Policy Ment Health"},{"key":"10303_CR35","unstructured":"Government of Canada. Classes of depreciable property. 2004. https:\/\/www.canada.ca\/en\/revenue-agency\/services\/tax\/businesses\/topics\/sole-proprietorships-partnerships\/report-business-income-expenses\/claiming-capital-cost-allowance\/classes-depreciable-property.html. Accessed 28 Jun 2022."},{"key":"10303_CR36","doi-asserted-by":"crossref","unstructured":"Zullo AR, Danko KJ, Moyo P, Adam GP, Riester M, Kimmel HJ, et al. Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults. Agency for Healthcare Research and Quality (AHRQ). 2020. https:\/\/effectivehealthcare.ahrq.gov\/products\/opioids-older-adults\/report. Accessed 15 Jun 2021.","DOI":"10.23970\/AHRQEPCTB37"},{"key":"10303_CR37","unstructured":"V\u00e9zina J, Giroux L. L\u2019\u00c9chelle des Emb\u00eatements: une \u00e9tude de validation et d\u2019adaptation du Hassles Scale pour une population adulte \u00e2g\u00e9e. Meeting of the Canadian Psychological Association; 1988; Montr\u00e9al, Qu\u00e9bec."},{"key":"10303_CR38","unstructured":"Hu\u1ef3nh C, Rochette L, Jutras-Aswad D, Larocque A, Fleury MJ, Kisely S, et al. Les troubles li\u00e9s aux substances psychoactives - Pr\u00e9valence des cas identifi\u00e9s \u00e0 partir des banques de donn\u00e9es administratives, 2001\u20132016: Bureau d\u2019information et d\u2019\u00e9tudes en sant\u00e9 des populations. 2019. https:\/\/www.inspq.qc.ca\/sites\/default\/files\/publications\/2512_troubles_substances_psychoactives_prevalence_cas_identifies.pdf. Accessed 23 Jun 2021."},{"issue":"5","key":"10303_CR39","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/CIRCOUTCOMES.113.000359","volume":"6","author":"MA Brookhart","year":"2013","unstructured":"Brookhart MA, Wyss R, Layton JB, St\u00fcrmer T. Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes. 2013;6(5):604\u201311.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"28","key":"10303_CR40","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661\u201379.","journal-title":"Stat Med"},{"key":"10303_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized Linear Models","author":"P McCullagh","year":"1989","unstructured":"McCullagh P, Nelder JA. Generalized Linear Models. 2nd ed. New York, NY: Chapman & Hall; 1989.","edition":"2"},{"issue":"5","key":"10303_CR42","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jgo.2019.01.012","volume":"10","author":"X Feng","year":"2019","unstructured":"Feng X, Higa GM, Safarudin F, Sambamoorthi U, Tan X. Potentially inappropriate medication use and associated healthcare utilization and costs among older adults with colorectal, breast, and prostate cancers. J Geriatr Oncol. 2019;10(5):698\u2013704.","journal-title":"J Geriatr Oncol"},{"issue":"22","key":"10303_CR43","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","volume":"163","author":"DM Fick","year":"2003","unstructured":"Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: Results of a US Consensus Panel of Experts. Arch Intern Med. 2003;163(22):2716.","journal-title":"Arch Intern Med"},{"issue":"12","key":"10303_CR44","first-page":"13","volume":"32","author":"G Carri\u00e8re","year":"2021","unstructured":"Carri\u00e8re G, Garner R, Sanmartin C. Significant factors associated with problematic use of opioid pain relief medications among the household population, Canada, 2018. Health Rep. 2021;32(12):13\u201326.","journal-title":"Health Rep"},{"key":"10303_CR45","doi-asserted-by":"crossref","unstructured":"Pitrou I, D\u2019Aiuto C, Lunghi C, Gu\u00e9nette L, Berbiche D, Bertrand K, et al. Changes in self-rated physical and mental health and life satisfaction associated with opioid and potentially inappropriate opioid prescribing in primary care older adults [Advance online publication]. Fam Pract. 2023;cmad050.","DOI":"10.1093\/fampra\/cmad050"},{"key":"10303_CR46","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.1046\/j.1532-5415.50.6s.1.x","volume":"50","author":"AGS Panel on Persistent Pain in Older Persons","year":"2002","unstructured":"AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc. 2002;50:S205\u201324.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10303_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3949\/ccjm.85a.16082","volume":"85","author":"N Siekman","year":"2018","unstructured":"Siekman N, Hilger R. High users of healthcare: Strategies to improve care, reduce costs. Cleve Clin J Med. 2018;85(1):25\u201331.","journal-title":"Cleve Clin J Med"},{"key":"10303_CR48","unstructured":"Organisation for Economic Co-operation and Development (OECD). Conversion rates - Purchasing power parities (PPP) - OECD Data. 2022. http:\/\/data.oecd.org\/conversion\/purchasing-power-parities-ppp.htm. Accessed 30 Sept 2023."},{"issue":"1","key":"10303_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pds.3334","volume":"22","author":"ES Johnson","year":"2013","unstructured":"Johnson ES, Bartman BA, Briesacher BA, Fleming NS, Gerhard T, Kornegay CJ, et al. The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf. 2013;22(1):1\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10303_CR50","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","volume":"158","author":"WA Ray","year":"2003","unstructured":"Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915\u201320.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10303_CR51","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0895-4356(94)00234-H","volume":"48","author":"R Tamblyn","year":"1995","unstructured":"Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Qu\u00e9bec. J Clin Epidemiol. 1995;48(8):999\u20131009.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-10303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-10303-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-10303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T06:04:34Z","timestamp":1700805874000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-10303-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["10303"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-10303-2","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"21 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was reviewed and approved by the Ethics Institutional Committee of the <i>CIUSSS Estrie-Centre Hospitalier Universitaire de Sherbrooke (CHUS)<\/i> (# 2021\u20133807). The access and use of administrative medical record data were approved by the provincial Commission de l\u2019Acc\u00e8s \u00e0 l\u2019Information du Qu\u00e9bec (CAI). Participants gave their written informed consent to participate in the study and to access\/merge their health administrative data. All methods were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Carina D\u2019Aiuto reports personal fees from Dialogue Health Technologies\u00a0during the conduct of the study. Carina D\u2019Aiuto received a doctoral scholarship from the Faculty of Medicine and Health Sciences (FMSS) at the University of Sherbrooke and from the Charles-Le Moyne Research Center (CR-CLM). The other authors have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1295"}}